Press Releases

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2020

September 3, 2020 at 7:00 AM EDT

CRANBURY, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the following virtual investor conferences in September:

  • Citi’s 15th Annual BioPharma Virtual Conference on Thursday, September 10, 2020 at 8:55 a.m. E.T.
  • Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020 at 10:00 a.m. E.T.
  • Bank of America Global Healthcare Conference on Friday, September 18, 2020 at 4:45 p.m. B.S.T. (11:45 a.m. E.T.)

A live audio webcast of each presentation can be accessed via the Investors section of the Amicus Therapeutics corporate website at

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at, and follow on Twitter and LinkedIn.


Amicus Therapeutics
Andrew Faughnan
Director, Investor Relations
(609) 662-3809

Amicus Therapeutics
Diana Moore
Head of Global Corporate Communications
(609) 662-5079